Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Clinical Trial Race, Ethnicity Categories Should Match OMB’s, FDA Says

Executive Summary

FDA is recommending that clinical trial sponsors collect information on the race and ethnicity of participants using standard Office of Management & Budget categories

You may also be interested in...



FDA Genomics Guidance, Demographics Database To Improve Gender Analysis

Electronic clinical trial databases under development at FDA's Office of Women's Health will help sponsors design trials that account for gender and other demographic differences among patients, FDA Commissioner McClellan said

FDA Genomics Guidance, Demographics Database To Improve Gender Analysis

Electronic clinical trial databases under development at FDA's Office of Women's Health will help sponsors design trials that account for gender and other demographic differences among patients, FDA Commissioner McClellan said

Pediatric Trial Sponsors Should Report Minority Enrollment, GAO Says

FDA should require drug sponsors conducting pediatric trials to use specific categories in reporting the race and ethnicity of participants, GAO said

Related Content

UsernamePublicRestriction

Register

PS041150

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel